ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
0.00%
Bitcoin
67,189.79
0.37%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Silence Therapeutics PLC (PK) (SLNCF)

  7. Silence Therapeutics PLC (PK) (SLNCF) News

SLNCF

Silence Therapeutics (PK) (SLNCF)

Silence Therapeutics PLC (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SLNCF
DateTimeSourceHeadlineSymbolCompany
08/05/202407:03Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersUSOTC:SLNCFSilence Therapeutics PLC (PK)
01/12/202323:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
01/11/202322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
16/08/202321:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
15/08/202307:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SLNCFSilence Therapeutics PLC (PK)
03/07/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
17/05/202306:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
01/05/202321:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
28/03/202323:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
09/02/202307:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SLNCFSilence Therapeutics PLC (PK)
13/01/202308:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
11/11/202200:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
21/10/202207:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:SLNCFSilence Therapeutics PLC (PK)
29/09/202222:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
23/08/202206:14Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
20/08/202206:31Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
13/08/202203:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:SLNCFSilence Therapeutics PLC (PK)
12/08/202220:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
12/08/202207:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
16/06/202206:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:SLNCFSilence Therapeutics PLC (PK)
16/05/202222:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
16/05/202222:33Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
25/04/202222:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
04/04/202222:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
23/03/202223:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
18/03/202203:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:SLNCFSilence Therapeutics PLC (PK)
22/02/202222:52Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
15/02/202209:23Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
15/02/202209:12Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
11/02/202208:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SLNCFSilence Therapeutics PLC (PK)
 Showing the most relevant articles for your search:USOTC:SLNCF

Your Recent History

BIT
NSCIT6933013
Snam
EU
B159S
B159S
LQID
VIETH
DBI
G86T
XUNZPPAU1CUSDINAV
USOTC
BOLL
Bollinger Industries (CE)
KUCN
GAMMAUSDT
Gamma
NASDAQ
WNDY
Global X Wind Energy ETF
EU
Y629S
Y629S
COIN
BNCBTC
IDCM
GBTBTC
Grabity Coin
HUOB
POLYXETH
Polymesh
BIT
P1WX80
NLBNPIT1WX80 20991231 27...
NYSE
AOHY
Angel Oak Funds
LSE
RUSL
Ly Russia Dis G
USOTC
SBGOF
Standard Bank (PK)
LSE
DP6A
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved